Related Experiment Video
Updated: May 7, 2026

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Celiac disease--prevention strategies through early infant nutrition
Abstract:
Celiac disease (CD) is an immune-mediated disease of considerable incidence, which negatively influences the quality of life of affected individuals and their families. The only currently available treatment is a lifelong gluten-free diet. Possible prevention strategies for CD focus on early infant feeding practices, namely breastfeeding and the time and mode of gluten introduction into the infant's diet. A systematic review of available data suggested that the risk of developing CD may be decreased by breastfeeding and breastfeeding at the time of gluten introduction. It is not clear whether this strategy prevents the disease or only delays the onset of symptoms. Gluten introduction should not be done earlier than at 4 months of age and not later than 7 months of age since both early and late introduction of gluten have been shown to increase the risk of CD. A large randomized controlled trial is being conducted in 10 European countries to clarify whether breastfeeding and early gluten introduction are effective in preventing CD in genetically susceptible individuals.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Preventive Healthcare Services
Chronic Pancreatitis II: Collaborative Care
Assessment:
Development of Human Microbiota

